An experimental study on the malignant characteristics of gemcitabine resistant cells by Transferring MiRNA-222-3p via exosomes

Minerva Surg. 2021 Oct;76(5):488-490. doi: 10.23736/S2724-5691.21.08888-2. Epub 2021 Jun 23.
No abstract available

MeSH terms

  • A549 Cells
  • Deoxycytidine / analogs & derivatives
  • Drug Resistance, Neoplasm*
  • Exosomes* / genetics
  • Gemcitabine
  • Humans
  • MicroRNAs* / genetics

Substances

  • MIRN222 microRNA, human
  • MicroRNAs
  • Deoxycytidine
  • Gemcitabine